- Feature Paper
- Review
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
- Bernhard W. Renz,
- Jan G. D’Haese,
- Jens Werner,
- C. Benedikt Westphalen and
- Matthias Ilmer
The diagnosis of pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis, in particular, when patients present with unresectable disease. While significant progress has been made in understanding the biology of PDAC, this knowledge has not...

